Profile
Albert Saporta is currently the Chairman at Stallergenes Ibérica SA, the Non-Executive Chairman at ASAP France SARL, the Director at Stallergenes Italia Srl, the Director at Alergovet SA, the Director at Stallergènes Sp zoo, the Director at Stallergenes, Inc., and the President & Director at Fabentech SAS. Previously, he served as the Chairman at Stallergenes Belgium SA from 2004 to 2012, the Chairman at Stallergenes AG, the Director at Stallergenes SA from 1999 to 2014, the Independent Director at Hybrigenics SA from 2012 to 2019, the Head-European Operations at Pasteur Merieux Serums et Vaccins SA, the Chief Investment Officer at Alternative Investment Management & Research SA, the Head-International Development at Pasteur Mérieux Connaught, and the Chief Financial Officer at Institut Mérieux SA.
Albert Saporta active positions
| Companies | Position | Start |
|---|---|---|
Stallergenes Ibérica SA | Chairman | 26/07/2010 |
Alergovet SA | Director/Board Member | 26/07/2010 |
Stallergènes Sp zoo | Director/Board Member | 01/01/2011 |
Stallergenes Italia Srl
Stallergenes Italia Srl Medical DistributorsDistribution Services Wholesales pharmaceutical products | Director/Board Member | 01/01/2009 |
Stallergenes, Inc. | Director/Board Member | 01/01/2011 |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | President | - |
ASAP France SARL | Chairman | - |
Former positions of Albert Saporta
| Companies | Position | End |
|---|---|---|
| ATON | Director/Board Member | 14/10/2019 |
| STALLERGENES | President | 13/01/2012 |
| ░░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░ ░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Pasteur Merieux Serums et Vaccins SA
Pasteur Merieux Serums et Vaccins SA BiotechnologyHealth Technology Operates a biomedical group | Health Technology |
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases | Health Technology |
Hybrigenics SA
Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Alternative Investment Management & Research SA
Alternative Investment Management & Research SA Alternative Investment Management & Research SA (AIM&R) is an alternative research and investment management firm which was founded in 1995 by Albert Saporta. Located in Geneva, Switzerland, AIM&R manages the S.O.G. Fund and SOGAsia hedge funds and managed accounts for sophisticated investors. In 2003 the firm formed a strategic alliance with United Overseas Bank Ltd., Singapore, through their subsidiary UOB Global Capital LLC, for the exclusive worldwide distribution of the SOGAsia Fund. AIM&R also advises hedge funds and trading groups. | |
Pasteur Mérieux Connaught | |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Health Technology |
Stallergenes Ibérica SA | Distribution Services |
Stallergenes Italia Srl
Stallergenes Italia Srl Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Stallergenes Belgium SA
Stallergenes Belgium SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergies | Health Technology |
Alergovet SA | |
Stallergenes AG
Stallergenes AG Pharmaceuticals: OtherHealth Technology Engages in the manufacture and distribution of products in the medical, diagnostic, and cosmetic fields | Health Technology |
Stallergènes Sp zoo | |
Stallergenes, Inc. | |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | Health Services |
ASAP France SARL |
- Stock Market
- Insiders
- Albert Saporta
















